Trial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Cancer

Vergote, IgnaceMirza, MansoorSehouli, JalidLorusso, DomenicaKose, FatihCibula, DavidWestermann, AnnekeCollins, DearbhaileBanerjee, SusanaOaknin, AnaSoumaoro, IbrahimaJain, ShwetaMonk, Bradley2023-09-142023-09-1420221048-891Xhttps://ijgc.bmj.com/content/ijgc/32/Suppl_3/A225.1.full.pdfhttp://hdl.handle.net/11727/10659enginfo:eu-repo/semantics/openAccessTrial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical CancerconferenceObject32Supplement 3A225A2250008992523004691525-1438